Get a free preliminary evaluation of your protocol design, based on real-world data on more than 200M patients. Learn more.
Join the real-world data revolution
Our on-demand platform, datasets, and consulting services connect the life sciences industry to patient data from around the globe.
TriNetX accelerates study design, trial operations, and post-approval research by putting real-world data into the hands of biopharmaceutical companies, study sites, and investigators.
Study Design & Feasibility
Select endpoints, biomarkers, and treatment durations based on real-world data spanning everything from diagnoses to genomic variants. Test criteria against patients receiving care now.
Site Selection & Patient Recruitment
Connect with healthcare organizations across the globe who supply our data. Invite them to participate in your study and contact pre-qualified patients.
Real-World Evidence Generation
With licensed datasets or analytic tools on our platform, answer questions of safety, efficacy, and value for all your stakeholders, from patients to regulators.
Patients
Protocols Analyzed
Trials Presented
A World of Data
Access continually refreshed, de-identified data from EHR, registries, and claims, integrated and mapped to clear and comprehensive terminology.
Data Linking
Demographics
Diagnoses
Genomics
Lab Results
Longitudinal Patient History
Medications
Mortality
Oncology
Patient Location
Procedures
Provider Notes (NLP)
Tumor Registry
Vitals
Delivered Your Way
Get answers at the speed of thought by using our on-demand platform, licensing full datasets, or working with our clinical data analysts.
Platform
Build and explore cohorts, compare outcomes, uncover treatment patterns, and more, right on our fast and powerful platform. Our platform is also where you will connect with healthcare organizations who supply our data and stand ready to join your trial.
Datasets
Download datasets that associate every diagnosis, lab result, and other observation to a date and an anonymized patient ID. Run more precise longitudinal analyses by importing this data into your preferred software package.
Consulting
Our Clinical Sciences team represents analysts, epidemiologists, and evidence strategists with decades of experience in every phase and therapeutic area of research. Make this team an extension of your own, for chart reviews, competitive analyses, and more.
Hear how sponsors and sites find their advantage with TriNetX
Whether you’re a sponsor looking to evaluate your study’s criteria, or a hospital eager to attract today’s most innovative trials, TriNetX has the data and tools you need. Hear how some of our power users at Sanofi, the Medical University of South Carolina, and the University of Arkansas for Medical Sciences are conducting more, and more informed, research.
News
Marshfield Clinic Research Institute Joins TriNetX to Increase Participation in High-Impact Clinical Trial Opportunities
The Marshfield Clinic Research Institute, a division of Marshfield Clinic Inc. and the largest private medical research institute in Wisconsin, has joined the TriNetX network to increase clinical trial opportunities for its largely rural patient population.
North Estonia Medical Centre Joins the TriNetX Network to Improve Collaboration with the International Research Community
The North Estonia Medical Centre, the leading teaching and research hospital in Estonia, has joined the TriNetX network to expand its collaboration efforts within the international community of research investigators and gain more visibility for the organization.
TriNetX and Takeda Enter Into Agreement to Drive Access to Real-World Data and Analytics
TriNetX announced today it has entered into an agreement with Takeda Pharmaceutical Company Limited (“Takeda”) to unlock the value of real-world data (RWD) and accelerate the delivery of transformative therapies to patients.
.@MCResearchInst has joined the @TriNetX network to boost #clinicaltrial research opportunities, increase engagement with industry sponsors, and bring new therapies to patients. https://lnkd.in/dhAu6wY
#COVID19 study from @uudbmi, @utahctsi developed #machinelearning models using @TriNetX #realworlddata to evaluate the glucose changes in #diabetes patients following a #coronavirus diagnosis @Sejal_Mistryyy, @RamGouripeddi https://bit.ly/3rqPpAt
That's a lot of codes! @matveyp from @TriNetX goes over the new #COVID19 concepts in the i2b2 #Ontology. Join us LIVE now, use passcode 483131 https://harvard.zoom.us/j/92196978982?pwd=dDJmeEs5Y01ibUp2akVLTzcrcUYwZz09%20Passcode:483131 #i2b2ts2021
North Estonia Medical Centre has joined the @TriNetX network to increase #clinicaltrial engagement with the international research community and enable their researchers to conduct #RWE studies with powerful #realworlddata https://bit.ly/2SxGEri
Happy to share our last article in @ThrombosisRese1! Chronic DOAC therapy at time of COVID-19 diagnosis did not improve clinical outcomes. Indeed, all-cause mortality, hospitalization and VTE were higher in DOAC-treated patients.
@LiverpoolCCS @TriNetX
Direct-acting oral anticoagulants use prior to COVID-19 diagnosis and associations with 30-day clinical outcomes
It is unclear if direct-acting oral anticoagulants (DOACs) use before hospitalization due to COVID-19 diagnosis would ...
www.sciencedirect.com